Related Experiment Video
Updated: Jul 3, 2026

09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Multiple sclerosis in South Africa
Girish Modi1, Andre Mochan, Madelein du Toit
1Division of Neurology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. gmodicns@mweb.co.za
Summary
This study surveyed 430 South African multiple sclerosis (MS) patients, finding demographics and treatment patterns similar to global data, but with under-utilization of disease-modifying treatments like interferon beta.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Limited epidemiological data exists for multiple sclerosis (MS) in South Africa.
- Understanding the patient population and treatment landscape is crucial for healthcare planning.
Purpose of the Study:
- To gather qualitative epidemiological data on multiple sclerosis (MS) in South Africa.
- To describe the demographic profile, diagnostic methods, MS types, and treatment patterns of South African MS patients.
Main Methods:
- A questionnaire was administered to 430 patients diagnosed with multiple sclerosis (MS).
- Data collected included diagnostic methods (MRI, lumbar puncture, evoked potentials), patient demographics, MS type, and treatments used.
- Statistical analysis of the collected qualitative data.
Main Results:
- The majority of respondents (71%) were aged 30-59 years, 73% were female, and 89% were white.
- Commonly used diagnostic tools included magnetic resonance imaging (MRI) scans (91%), lumbar punctures (64%), and evoked potentials (49%).
- Relapsing-remitting MS was the most prevalent type (46%), while disease-modifying treatment was under-utilized, with 32% not using any, 30% using methotrexate, and 22% using interferon beta.
Conclusions:
- The demographic and clinical profiles of South African MS patients align with international findings.
- There is a notable under-utilization of interferon beta as a disease-modifying treatment in this population.
- Further research and targeted interventions are needed to optimize MS management in South Africa.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

